Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Top News

Untapped job-creation potential seen in sciences, biotechnology

by
December 12, 2024
in Top News
0
Untapped job-creation potential seen in sciences, biotechnology
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter
UNSPLASH

PHILIPPINE sciences are being held back by shortcomings in infrastructure and the dearth of incentives, limiting the sector’s capacity to unlock jobs and investment, industry representatives said.

“The limited career opportunities in the biopharmaceutical sector hinder the development of future scientists and experts, preventing them from gaining experience in good clinical and manufacturing practices,” Diana M. Edralin, president of the Pharmaceutical and Healthcare Association of the Philippines (PHAP), said in an e-mail.

“This not only undermines the potential for high-quality job creation within the country, but also represents a missed opportunity to position the nation as a clinical trial hub in Southeast Asia.”

Raul V. Destura, founder and chief executive officer of biotech startup Manila HealthTek, Inc., said the Philippines does not lack graduates and experts needed to expand its science and biotechnology sector.

“Actually, there are a lot of scientists who are really well-trained,” Mr. Destura told BusinessWorld on the sidelines of an event last month.

“It’s not really a shortage (that’s the problem,) but the lack of additional slots for them.”

Mr. Destura, who is also a medical doctor, said science graduates typically venture into the medical field or work as a research assistants or professors.

“But there is a subset of people who want to become researchers, scientists, inventors, biotechnologists. The current landscape is not enough to absorb all of these people,” he said.

Manila HealthTek, Inc. develops, manufactures, and tests portable diagnostic kits for selected infectious diseases affecting both human and animal health.

“The more we expand, the better-positioned we are to provide opportunities for our great Filipino scientists who can actually find careers in science… and not leave the country,” Mr. Destura said.

Meanwhile, Ms. Edralin, who also serves as the vice-president of the European Chamber of Commerce of the Philippines, cited the need for government support for innovation to attract more biopharmaceutical investment.

“Our country has the needed expertise, hospital facilities, and desirable demographics to support clinical trials for various conditions. However, despite these advantages, we acknowledge a concerning decline in our regional standings for clinical trials,” according to Ms. Edralin.

According to the PHAP, the Philippines used to rank second in the region in the conduct of clinical trials. It currently ranks fourth, behind Singapore, Thailand and Malaysia.

The competitiveness of Philippine-based clinical trials are also hampered by challenges in review timelines, limited infrastructure and support mechanisms, and the lack of publicly available disease registries, Ms. Edralin said.

There is also a need to harmonize regulatory pathways to streamline the approval process for clinical trials, especially for drugs for public health emergencies and rare or neglected diseases, she added.

“For competition to be vibrant, government spending must increase, pooled procurement must be implemented, and coverage to outpatient medicines must be expanded.” — Beatriz Marie D. Cruz

ShareTweetPin

Related Posts

Have a taste of the perfect day in paradise with SULÀ Spirits
Top News

Have a taste of the perfect day in paradise with SULÀ Spirits

January 8, 2025
First months of 2025 likely rainy amid La Niña conditions, says PAGASA
Top News

First months of 2025 likely rainy amid La Niña conditions, says PAGASA

January 8, 2025
December inflation rises to 2.9%
Top News

December inflation rises to 2.9%

January 7, 2025
Outstanding debt hits fresh high of P16.09T
Top News

Outstanding debt hits fresh high of P16.09T

January 7, 2025
Outstanding debt hits fresh high of P16.09T
Top News

Outstanding debt hits fresh high of P16.09T

January 7, 2025
PHL end-December dollar reserves drop to $106.8B
Top News

PHL end-December dollar reserves drop to $106.8B

January 7, 2025
Next Post
Philippine banks’ assets expand to P26.41 trillion

Philippine banks’ assets expand to P26.41 trillion

Recommended

On airports and attaining fiscal balance

On airports and attaining fiscal balance

December 16, 2024
Sangley Point: Airport or freeport?

Sangley Point: Airport or freeport?

October 23, 2024
Top 5 Canadian Mining Stocks This Week: Mkango Gains 90 Percent on Spin-out News

Top 5 Canadian Mining Stocks This Week: Mkango Gains 90 Percent on Spin-out News

July 5, 2025
Mapua Cardinals gun for share of NCAA lead against LPU Pirates

Mapua Cardinals gun for share of NCAA lead against LPU Pirates

September 23, 2024
Taiwan optical fiber company registers $70-M Batangas project with PEZA

Taiwan optical fiber company registers $70-M Batangas project with PEZA

October 2, 2024
Moonpig slips into loss after £50m write-down hits experiences division

Moonpig slips into loss after £50m write-down hits experiences division

December 11, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved